A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort. uri icon

authors

  • Sreenath, Nihanthy D
  • Mulajker, Deepak
  • Pandalanghat, Suresh
  • Kapoor, Amul
  • Govind, Rajath
  • Kaushik, M R
  • Nair, Rajesh
  • Bhuva, Dipen
  • Rathore, Anvesh
  • Manish Kumar, MD

publication date

  • August 18, 2025